OOIR: Observatory of International Research

Papers

(The median citation count of Substance Abuse is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Training Providers of People Who Use Drugs to Offer Hepatitis C Treatment: A Washington State Initiative	53
Associations Between Patient-Reported Experiences with Opioid Use Disorder Treatment and Unmet Treatment Needs and Discontinuation Among Virginia Medicaid Members	40
Perceived Impact of COVID-19 on Prevention, Treatment, Harm Reduction, and Recovery Services for Opioid use Disorder: National Survey of Local Health Departments	37
Patients with Substance use Disorders Receiving Continued Care in Skilled Nursing Facilities following Hospitalization	37
Commentary Article: Strategic Planning for Addiction Programs within Academic Medical Centers: Examples from the Yale Program in Addiction Medicine	36
Developing and Validating An Opioid Overdose Prevention and Response Curriculum for Undergraduate Medical Education	35
Mobile Phone and Internet use among People who Inject Drugs: Implications for Mobile Health Interventions	35
Multidisciplinary Treatment of Opioid use Disorder in Primary Care using the Collaborative Care Model	34
Coverage of the Opioid Crisis in National Network Television News from 2000–2020: A Content Analysis	32
The Association of Vaping With Social/Emotional Health and Attitudes Toward COVID-19 Mitigation Measures in Adolescent and Young Adult Cohorts During the COVID-19 Pandemic	32
Awareness of Heated Tobacco Products among US Adults – Health Information National Trends Survey, 2020	30
Alcohol Consumption and Alcohol Home Delivery Laws during the COVID-19 Pandemic	30
The Metropolitan Context of Substance use and Substance use Disorders among US Adults on Probation or Parole Supervision	29
Predictors of Substance use Disorder Treatment Initiation and Engagement among Adolescents Enrolled in Medicaid	28
Collaboration in a Time of Crisis: Adapting a Telementoring ECHO for Addiction Leaders during COVID-19	28
MIRRORS Program: Helping Pregnant and Postpartum Women and Families with Substance use Problems	27
Evaluating ACGME-Accredited Addiction Psychiatry Fellowship Online Content: A Critical Analysis of Addiction Psychiatry Fellowship Program Websites in the US	26
Research Priorities for Expansion of Opioid Use Disorder Treatment in the Community Pharmacy	25
Harms Versus Harms: Rethinking Treatment for Patients on Long-Term Opioids	25
A Systematic Literature Review and Narrative Synthesis of Effective Interventions for Family and Caregivers of People who use Methamphetamine	25
Using Data Science to Improve Outcomes for Persons with Opioid use Disorder	23
Leveraging Technology to Address Unhealthy Drug use in Primary Care: Effectiveness of the Substance use Screening and Intervention Tool (SUSIT)	23
Perspectives among Women Receiving Medications for Opioid use Disorder: Implications for Development of a Peer Navigation Intervention to Improve Access to Family Planning Services	23
“Narcan Encounters:” Overdose and Naloxone Rescue Experiences among People who use Opioids	22
Improving Medical Students’ Attitude toward Patients with Substance use Problems through Addiction Medicine Education	21

The “High Cost of Low Living”: Substance use Recovery among Older Formerly Homeless Adults	20
“And Then the Rest Happened”— a Qualitative Exploration of the Role that Meaningful Activities Play in Recovery Processes for People with a Diagnosis of Substance use Disorder	20
Care Practices of Mental Health Clinical Pharmacist Practitioners Within an Interdisciplinary Primary Care Model for Patients With Substance Use Disorders	19
Assessing Assessments: Substance use Disorder Treatment Providers’ Perceptions of Intake Assessments	19
Exploring the Association of State Policies and the Trajectories of Buprenorphine Prescriber Patient Caseloads	19
Contextual Challenges in Police-Assisted Substance use Referral Programs: Impact of COVID-19 and Black Lives Matter Movement	19
Latent Profile Analysis in Recovery Homes: A Single Quantitative Dimension Captures Most but Not All of the Important Details of the Recovery Process	18
A National Study of Homelessness, Social Determinants of Health, and Treatment Engagement Among Outpatient Medication for Opioid Use Disorder-Seeking Individuals in the United States	18
Physical Therapists’ Attitudes are Associated with their Confidence in and the Frequency with which they Engage in Prescription Opioid Medication Misuse Management Practices with their Patients. A Cro	17
An Examination of how E-Cigarette/Cigarette use during Adolescence is Associated with Future use during the Third Trimester of Pregnancy	17
How Essential is Kratom Availability and use during COVID-19? Use Pattern Analysis Based on Survey and Social Media Data	16
Impact of Stigmatizing Language Describing Opioid-Exposed Mother Infant Dyads: A Randomized Case Vignette Study	16
National Trends in Buprenorphine Treatment for Opioid Use Disorder From 2007 to 2018	16
Erratum to Volume 44 Issue 1-2, January-April 2023	16
Effects of Smoking Marijuana on the Respiratory System: A Systematic Review	15
Increasing Preference for Fentanyl among a Cohort of People who use Opioids in Vancouver, Canada, 2017-2018	15
Policies regarding Use of Medications for Opioid Use Disorder in Professional Recovery Programs: A Scoping Review	15
The Effects of Screening Brief Intervention Referral to Treatment (SBIRT) Training on Health Professional Trainees’ Regard, Attitudes, and Beliefs toward Patients who use Substances	15
Interventions for Hospitalized Medical and Surgical Patients with Opioid use Disorder: A Systematic Review	15
Predictors and Moderators of Response to Brief Interventions among Adolescents with Risky Alcohol and Marijuana Use	14
Rates of Discontinuation and Non-Publication of Trials for the Pharmacologic Treatment of Alcohol use Disorder	14
Childhood Trauma and the Severity of past Suicide Attempts in Outpatients with Cocaine use Disorders	14
Cardiac Surgeons’ Practices and Attitudes toward Addiction Care for Patients with Substance use Disorders	13
An Unsupervised Machine Learning Approach for the Detection and Characterization of Illicit Drug-Dealing Comments and Interactions on Instagram	13
Caregivers of People with Substance use or Mental Health Disorders in the US	13
Concerts, Bars, Parties, and Raves: Differential Risk for Drug use among High School Seniors According to Venue Attendance	13
Understanding Sexual and Gender Minority Substance use through Latent Profiles of Ecological Systems	13
Physician Trainees’ Compassion Satisfaction, Burnout, and Self-Efficacy When Caring for People who Inject Drugs	13
Commentary Article: Opioid use Disorder Cascade of Care Framework Design: A Roadmap	13
Project ECHO and Primary Care Buprenorphine Treatment for Opioid use Disorder: Implementation and Clinical Outcomes	13
Evaluation of the New England Office Based Addiction Treatment ECHO: A Tool for Strengthening the Addiction Workforce	13
Opioid-Related Incident Severity and Emergency Medical Service Naloxone Administration by Sex in Massachusetts, 2013–2019	13
Use of Pre-Enrollment Randomization and Delayed Consent to Maximize Participation in a Clinical Trial of Opt-In versus Opt-Out Tobacco Treatment	13
Characteristics Associated with Motivation to Stop Substance use and Improve Skin and Needle Hygiene among Hospitalized Patients who Inject Drugs	13
Food Insecurity and Substance use in People with HIV Infection and Substance use Disorder	12
Alcohol and Educational Inequalities: Hazardous Drinking Prevalence and All-Cause Mortality by Hazardous Drinking Group in People Aged 50 and Older in Europe	12
“The Idea is to Help People Achieve Greater Success and Liberty”: A Qualitative Study of Expanded Methadone Take-Home access in Opioid use Disorder Treatment	12
The Impact of Obesity in Patients Hospitalized with Opioid/Opiate Overdose	12
Cervical Cancer Screening, Abnormal Results, and Follow-Up in Women with Substance Use-Related Diagnoses	12
Attitudes, Self-Efficacy, and Practices Related to Opioid Risk Assessment and Mitigation: A Comparison of Health Care Professionals in Rural Communities	12
Perceptions of Peer and Parental Attitudes toward Substance use and Actual Adolescent Substance Use: The Impact of Adolescent-Confidant Relationships	12
Profiles of Individuals with Cannabis-Related Disorders	12
Increasing Buprenorphine access for Veterans with Opioid use Disorder in Rural Clinics using Telemedicine	11
Opioid Harm Reduction: A Scoping Review of Physician and System-Level Gaps in Knowledge, Education, and Practice	11
Sociodemographic Differences in Quality of Treatment to Medicaid Enrollees Receiving Buprenorphine	11
One Year Mortality of Patients Treated with Naloxone for Opioid Overdose by Emergency Medical Services	10
Factors Associated with Nurses’ Motivation to Provide Care for Patients with Alcohol Use and Alcohol Use-Related Problems	10
The Impact of Sexual Victimization on Substance Use Disorder Treatment Completion: A Systematic Review and Meta-Analysis	10
Co-use of Opioid Medications and Alcohol Prevention Study (COAPS)	10
Impact of the International Collaborative Addiction Medicine Research Fellowship on Physicians’ Future Engagement in Addiction Research	10

Use of Project ECHO to Promote Evidence Based Care for Justice Involved Adults with Opioid use Disorder	10
Trends in Cannabis-Related Attitudes and Behaviors among Cannabis-Using Adolescent and Young Adult Outpatients following Medical Cannabis Legalization in Massachusetts	10
Youth Risk Profiles and their Prediction of Distal Cannabis and Tobacco co-use in the Population Assessment of Tobacco Health (PATH)	10
A Bridge Too Far? Distance to Waivered Physicians and Utilization of Buprenorphine Treatment for Opioid use Disorder in West Virginia Medicaid	9
Safety and Efficacy of a Digital Therapeutic for Substance use Disorder: Secondary Analysis of Data from a NIDA Clinical Trials Network Study	9
Opioid use during Pregnancy: An Analysis of Comment Data from the 2016 Pregnancy Risk Assessment Monitoring System Survey	9
Use of Electronic Cigarettes among U.S. Military Service Members – Prevalence and Associated Risk Factors	9
Alcohol use Disorder in Active Duty Service Members: Incidence Rates over a 19-Year Period	9
The Feasibility and Safety of Training Patients in Opioid Treatment to Serve as Peer Recovery Support Service Interventionists	9
Gaps in Naloxone Ownership among People who Inject Drugs during the Fentanyl Wave of the Opioid Overdose Epidemic in New York City, 2018	9
Commentary Article: Study Protocol for the Respond to Prevent Study: A Multi-State Randomized Controlled Trial to Improve Provision of Naloxone, Buprenorphine and Nonprescription Syringes in Community	9
Are COVID-19 Health-Related and Socioeconomic Stressors associated with Increases in Cannabis use in Individuals who use Cannabis for Recreational Purposes?	8
Perioperative Management of Extended-Release Buprenorphine: A Narrative Review and Case Series	8
Internet use and Uptake of a Web-Based Prevention and Risk Reduction Intervention for Persons who use Drugs in New York City – Webhealth4Us Study (2013–2016)	8
Understanding Opioid Overdose Risk and Response Preparedness among People who use Cocaine and other Drugs: Mixed-Methods Findings from a Large, Multi-City Study	8
Familial Support in Integrated Treatment with Antiretroviral Therapy and Medications for Opioid use Disorder in Vietnam: A Qualitative Study	8
Spice, Vulnerability, and Victimization: Synthetic Cannabinoids and Interpersonal Crime Victimization among Homeless Adults	8
Legal Status of Recreational Cannabis and Self-Reported Substitution of Cannabis for Opioids or Prescription Pain Medication in Canada and the United States	8
Stigmatization of Medications for Opioid use Disorder in 12-Step Support Groups and Participant Responses	7
Implementation and Evaluation of Primary Care Team Participation in Opioid Use Disorder Learning Sessions	7
COVID-19-Related Policy Changes for Methadone Take-Home Dosing: A Multistate Survey of Opioid Treatment Program Leadership	7
The Role of Executive Functioning Deficits in the Association between Substance-use-Related Stigma and Substance use Problems among Trauma-Exposed Individuals	7
Clinical and Demographic Differences in the Willingness to use Self-Administered At-Home COVID-19 Testing Measures among Persons with Opioid use Disorder	7
Evaluating a Video-Based Addiction Curriculum at a Safety Net Academic Medical Center	7
A Case of Dry Beriberi from Alcohol use Disorder and Disordered Eating	7
Health Professionals’ Attitudes toward Medications for Opioid use Disorder	7
The Impact of Access to Addiction Specialist on Attitudes, Beliefs and Hospital-Based Opioid Use Disorder Related Care: A Survey of Hospitalist Physicians	7
A National Survey of Barriers and Facilitators to Medications for Opioid use Disorder among Legal-Involved Veterans in the Veterans Health Administration	6
High-Intensity Drinking among Adolescent and Emerging Adult Risky Drinkers	6
Real-World Study of Multiple Naloxone Administrations for Opioid Overdose Reversal among Emergency Medical Service Providers	6
Preparing for the Future of Medical Education: A Case Series of Traditional and Virtual Clinical Rotations in Addiction Medicine Spanning the COVID Pandemic	6
Exploring how Hospitalization Can Alter Hepatitis C Virus Treatment Prioritization and Trajectories in People who Use Drugs: A Qualitative Analysis	6
Longitudinal Evaluation of Pharmacists’ Social Distance Preference and Attitudes toward Patients with Opioid Misuse following An Educational Training Program	6
Social Relationships, Homelessness, and Substance use among Emergency Department Patients	6
Reward Sensitivity and Hazardous Alcohol Consumption in Women: The Parallel Mediation Effect of Self-Control and Impulsivity Traits	6
Leveraging National Data and Regional Innovations to Right-Size Tobacco Treatment Policy for Behavioral Health in a Midwestern State	6